Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

1.

Pneumococcal transmission and disease in silico: a microsimulation model of the indirect effects of vaccination.

Nurhonen M, Cheng AC, Auranen K.

PLoS One. 2013;8(2):e56079. doi: 10.1371/journal.pone.0056079. Epub 2013 Feb 6.

PMID:
23457504
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.

Weil-Olivier C, van der Linden M, de Schutter I, Dagan R, Mantovani L.

BMC Infect Dis. 2012 Sep 7;12:207. doi: 10.1186/1471-2334-12-207. Review.

PMID:
22954038
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Nasopharyngeal colonization: a target for pneumococcal vaccination.

Käyhty H, Auranen K, Nohynek H, Dagan R, Mäkelä H.

Expert Rev Vaccines. 2006 Oct;5(5):651-67. Review.

PMID:
17181439
[PubMed - indexed for MEDLINE]
4.

Serotype replacement in disease after pneumococcal vaccination.

Weinberger DM, Malley R, Lipsitch M.

Lancet. 2011 Dec 3;378(9807):1962-73. doi: 10.1016/S0140-6736(10)62225-8. Epub 2011 Apr 12. Review.

PMID:
21492929
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Continued control of pneumococcal disease in the UK - the impact of vaccination.

Gladstone RA, Jefferies JM, Faust SN, Clarke SC.

J Med Microbiol. 2011 Jan;60(Pt 1):1-8. doi: 10.1099/jmm.0.020016-0. Epub 2010 Oct 21. Review.

PMID:
20965923
[PubMed - indexed for MEDLINE]
Free Article
6.

Cost effectiveness of pneumococcal conjugate vaccination against acute otitis media in children: a review.

Boonacker CW, Broos PH, Sanders EA, Schilder AG, Rovers MM.

Pharmacoeconomics. 2011 Mar;29(3):199-211. doi: 10.2165/11584930-000000000-00000. Review.

PMID:
21250759
[PubMed - indexed for MEDLINE]
7.

The pharmacoeconomics of pneumococcal conjugate vaccines in Latin America.

Giglio N, Micone P, Gentile A.

Vaccine. 2011 Sep 14;29 Suppl 3:C35-42. doi: 10.1016/j.vaccine.2011.06.095. Review.

PMID:
21896351
[PubMed - indexed for MEDLINE]
8.

Streptococcus pneumoniae--a review of carriage, infection, serotype replacement and vaccination.

Mehr S, Wood N.

Paediatr Respir Rev. 2012 Dec;13(4):258-64. doi: 10.1016/j.prrv.2011.12.001. Epub 2012 Jan 18. Review.

PMID:
23069126
[PubMed - indexed for MEDLINE]
9.

Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.

Dagan R.

Clin Microbiol Infect. 2009 Apr;15 Suppl 3:16-20. doi: 10.1111/j.1469-0691.2009.02726.x. Review.

PMID:
19366365
[PubMed - indexed for MEDLINE]
10.

The fundamental link between pneumococcal carriage and disease.

Simell B, Auranen K, Käyhty H, Goldblatt D, Dagan R, O'Brien KL; Pneumococcal Carriage Group.

Expert Rev Vaccines. 2012 Jul;11(7):841-55. Review.

PMID:
22913260
[PubMed - indexed for MEDLINE]
11.

Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance.

Klugman KP.

Lancet Infect Dis. 2001 Sep;1(2):85-91. Review.

PMID:
11871480
[PubMed - indexed for MEDLINE]
12.

[Pneumococcal vaccination: expected benefits in adults].

Temime L, Dab W.

Rev Med Interne. 2007 Jan;28(1):9-15. Epub 2006 Sep 18. Review. French.

PMID:
17010485
[PubMed - indexed for MEDLINE]
13.

Economic evaluations of pneumococcal vaccination strategies in adults. A summary of the results.

Thiry N, Beutels P, Van Damme P.

Acta Clin Belg. 2005 Nov-Dec;60(6):338-44. Review.

PMID:
16502594
[PubMed - indexed for MEDLINE]
14.

Effective management in clusters of pneumococcal disease: a systematic review.

Basarab M, Ihekweazu C, George R, Pebody R.

Lancet Infect Dis. 2011 Feb;11(2):119-30. doi: 10.1016/S1473-3099(10)70281-4. Review.

PMID:
21272792
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk